No loading phase is needed, and there's no evidence that tapering on or off changes outcomes
Nanoparticles responsive to GSH are capable of delivering both chemotherapeutic drugs and inhibitors, such as an oxaliplatin-based prodrug combined with an IDO-1 inhibitor (indoleamine 2,3-dioxygenase 1)
About This Article Special Topic Disclaimer/Publishers Note: All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s) and do not necessarily reflect those of OAE and/or the editor(s)
While they don't change the underlying disease process in arthritis, they significantly improve quality of life when used alongside disease-modifying treatments (American College of Rheumatology, n.d
Human data remains weak and small
While the effects may not be immediate, consistent use can lead to gradual improvements in skin tone and texture